Potentiation of (177)Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor

por Purohit, Nupur K., Shah, Rashmi G., Adant, Samuel, Hoepfner, Michael, Shah, Girish M., Beauregard, Jean-Mathieu
Publicado 2018

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of (177)Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells

por Shah, Rashmi G., Merlin, Marine A., Adant, Samuel, Zine-Eddine, Fayçal, Beauregard, Jean-Mathieu, Shah, Girish M.
Publicado 2021